ArticleActa pharmaceutica Sinica. B2022

Fully synthetic Tn-based three-component cancer vaccine using covalently linked TLR4 ligand MPLA and iNKT cell agonist KRN-7000 as built-in adjuvant effectively protects mice from tumor development.

Deying Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.